96792-08-4

Upstream product

• 5006-22-4 Cyclobutanecarbonyl chloride 
• 96867-09-3 N^ε-(benzyloxycarbonyl)-N^α-(cyclobutylcarbonyl)-L-lysine methyl ester 
• 24498-31-5 (S)-methyl 2-amino-6-(benzyloxycarbonylamino)hexanoate 
• 96867-10-6 N₂-(Cyclobutylcarbonyl)-N₆-[(phenylmethoxy)-carbonyl]-L-lysine 

Downstream Products

• 96792-11-9 5(S)-<α-(cyclobutylcarbonyl)-L-lysyl>amino>-4-oxo-6-phenylhexanoyl-L-proline hydroxylamide 
• 96792-13-1 succinimidyl 5(S)-<ε-(butyloxycarbonyl)-N^α-(cyclobutylcarbonyl)-L-lysyl>amino>-4-oxo-6-phenylhexanoate 
• 96792-10-8 5(S)-<ε-(butyloxycarbonyl)-N^α-(cyclobutylcarbonyl)-L-lysyl>amino>-4-oxo-6-phenylhexanoyl-L-proline hydroxylamide 
• 96867-12-8 2-(2-carboxyethyl)-2-<1(S)-<ε-(benzyloxycarbonyl)-N^α-(cyclobutylcarbonyl)-L-lysyl>amino>-2-phenylethyl>-1,3-dioxolane 
• 96792-09-5 5(S)-<ε-(butyloxycarbonyl)-N^α-(cyclobutylcarbonyl)-L-lysyl>amino>-4-oxo-6-phenylhexanoic acid 

Relevant academic research and scientific papers

Synthesis and biological activity of pentapeptide analogues of the potent angiotensin converting enzyme inhibitor 5(S)-benzamido-4-oxo-6-phenylhexanoyl-L-proline

Two pentapeptide analogues (14 and 15) of the ketomethylene-containing angiotensin converting enzyme (ACE) inhibitor 5(S)-benzamido-4-oxo-6-phenylhexanoyl-L-proline (1) were synthesized and evaluated as ACE inhibitors and antihypertensive agents. Compound